Business Context and Reporting Period
The submitted filing is Ambac Financial Group, Inc.’s unaudited Form 10-Q for the quarter ended March 31, 2021, filed May 10, 2021. The request metadata identifies “OCTAVE SPECIALTY GROUP INC,” but the filing itself identifies Ambac Financial Group, Inc. as the registrant.
Ambac operates legacy financial guarantee insurance businesses in runoff, including Ambac Assurance Corporation and Ambac Assurance UK Limited, while developing specialty property and casualty insurance through Everspan and managing general agency/underwriting businesses through Xchange.
Key Financial Metrics
| Metric | Q1 2021 | Q1 2020 or Prior Period |
|---|---|---|
| Total revenues | $129 million | $(70) million |
| Net income attributable to common stockholders | $17 million | $(280) million |
| Diluted earnings per share | $0.08 | $(6.07) |
| Net cash used in operating activities | $(40) million | $(87) million |
| Net cash provided by investing activities | $116 million | $244 million |
| Net cash used in financing activities | $(69) million | $(146) million |
| Ending cash, cash equivalents and restricted cash | $42 million | $91 million |
| Total assets | $12.840 billion | $13.220 billion at December 31, 2020 |
| Total liabilities | $11.697 billion | $12.074 billion at December 31, 2020 |
| Total stockholders’ equity | $1.123 billion | $1.140 billion at December 31, 2020 |
| Long-term debt | $2.661 billion | $2.739 billion at December 31, 2020 |
- Net premiums earned were $14 million, compared with $10 million in Q1 2020.
- Net investment income was $49 million, versus a $21 million loss in Q1 2020, primarily reflecting improved pooled-fund and other-investment performance.
- Net gains on derivative contracts were $25 million, compared with a $70 million loss in Q1 2020, driven by rising forward interest rates and improved counterparty credit adjustments.
- Losses and loss expenses were $8 million, compared with $117 million in Q1 2020. Q1 2021 included $9 million of adverse development in domestic public finance, primarily related to Puerto Rico, partly offset by favorable RMBS development.
- Operating expenses increased to $33 million from $24 million, reflecting Xchange costs, higher commissions, consulting and legal expenses, and compensation-related items.
- Interest expense declined to $50 million from $63 million, primarily due to lower Ambac Note costs, optional debt redemptions and lower discount accretion.
- Adjusted earnings, a non-GAAP measure, were $41 million, or $0.59 per diluted share, compared with an adjusted loss of $265 million, or $5.75 per diluted share, in Q1 2020.
- Adjusted book value was $908 million, or $19.66 per share, compared with $919 million, or $20.05 per share, at December 31, 2020.
Material Changes Versus Prior Comparable Period
- Results improved substantially from the COVID-19-driven market disruption in Q1 2020, when falling interest rates, credit deterioration and investment-market losses materially reduced earnings.
- Q1 2021 included a $33 million gain from extinguishment of debt and a $4 million gain related to the Corolla Trust exchange. These items were unusual and materially benefited reported earnings.
- Ambac completed exchanges of the Corolla Notes and junior surplus notes. AAC issued approximately $280 million of senior surplus notes in total, and all junior surplus notes were canceled. Surplus-note principal outstanding after the transactions was $853 million.
- Financial guarantee net par exposure declined 7% to $31.447 billion from $33.888 billion at year-end 2020. Adversely classified exposure declined 10% to $7.603 billion.
- Risk reduction included quota-share reinsurance on approximately $823 million of public-finance net par exposure and elimination of a $540 million adversely classified stadium exposure through refinancing and quota-share reinsurance.
- AFG contributed approximately $82 million of additional capital to Everspan. Everspan received an A- Financial Strength Rating from A.M. Best in February 2021.
- Statutory policyholder surplus at AAC declined to $733 million from $865 million at December 31, 2020, primarily due to a $153 million statutory net loss, partly offset by $20 million of net investment gains recorded directly through surplus.
Guidance, Outlook, Risks and Unusual Items
- No formal earnings or financial guidance was provided. Management stated that quarterly results may not be indicative of full-year 2021 results.
- Management remains focused on runoff and de-risking of the legacy financial guarantee portfolio, capital and liability rationalization, litigation recoveries, operating efficiency, and measured growth in specialty property and casualty and MGA/U businesses.
- Puerto Rico remains the principal uncertainty. Ambac reported approximately $1.067 billion of Puerto Rico net par exposure and recorded $9 million of domestic public-finance losses in Q1 2021. The Second Amended Plan of Adjustment and related restructuring proposals could materially change recoveries and reserves.
- For public-finance credits with expected losses, management estimated possible additional loss reserves of approximately $660 million under stress or adverse conditions. Such losses would reduce stockholders’ equity from $1.123 billion to approximately $463 million.
- Ambac recorded $1.722 billion of net RMBS representation-and-warranty subrogation recoveries. If these recoveries were not realized, management estimated that stockholders’ equity could decline to approximately negative $598 million.
- COVID-19 continues to create uncertainty for municipal, RMBS, student-loan and other insured exposures, although fiscal stimulus, vaccination and economic recovery provided support during the quarter.
- OCI approval is required for payments on AAC surplus notes. In May 2021, OCI declined AAC’s request to pay principal and accrued interest scheduled for June 7, 2021. Accrued and unpaid interest on third-party surplus notes was $516 million at March 31, 2021.
- Ambac UK remained below applicable Solvency II capital requirements, with eligible capital resources of £212 million versus regulatory requirements of £246 million, a £35 million shortfall at March 31, 2021.
- AFG’s liquidity was $274 million, consisting primarily of cash, short-term investments and other net assets. AAC dividends to AFG are considered highly unlikely in the foreseeable future, making intercompany cost-allocation payments an important near-term source of parent liquidity.
- Material litigation and regulatory risks include Puerto Rico restructuring proceedings, RMBS recovery litigation, student-loan matters, potential regulatory intervention and disputes over insured-credit recoveries.
Important Facts for Investors to Verify
- Confirm the registrant identity: the filing is for Ambac Financial Group, Inc., not Octave Specialty Group Inc.
- Assess the sustainability of the $17 million GAAP profit after excluding the $33 million debt-extinguishment gain, the Corolla-related gain and favorable market-value movements.
- Review Puerto Rico restructuring developments, including the Second Amended Plan of Adjustment and the PRHTA/CCDA agreement, and their effect on loss reserves.
- Evaluate the collectability and timing of the $1.722 billion of RMBS representation-and-warranty recoveries.
- Monitor AAC statutory surplus, OCI approval of surplus-note payments, accrued interest and the potential for rehabilitation proceedings.
- Review liquidity at AFG, AAC and AFS separately, including derivative collateral requirements and the absence of expected AAC dividends.
- Assess Ambac UK’s regulatory capital shortfall and the limited options identified by management to address it.
- Review the company’s non-GAAP reconciliations and distinguish adjusted earnings and adjusted book value from GAAP results.